http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040002975-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2002-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040002975-A |
| titleOfInvention | Imidazo[1,5-a]pyrimido[5,4-d]benzazepine derivatives as gaba a receptor modulators |
| abstract | The present invention relates to compounds of formula (I) and pharmaceutically acceptable acid addition salts thereof:n n n Formula In n n n n n n n Wheren n n R 1 is halogen or lower alkyl,n n n R 2 is hydrogen, lower alkyl, cycloalkyl,-(CH 2 ) m -phenyl, wherein the phenyl ring may be substituted by lower alkoxy, or-(CH 2 ) m -indolyl,n n n R 3 is —C (O) O-lower alkyl, —C (O) OH, or a 5-membered heteroaromatic group, wherein the ring may be substituted by lower alkyl or cycloalkyl,n n n n is 0, 1 or 2,n n n m is 0, 1 or 2.n n n Compounds of this class have been shown to exhibit high affinity and selectivity for GABA A α5 receptor binding sites and may be useful for the treatment of cognitive enhancers or for treating cognitive disorders such as Alzheimer's disease. |
| priorityDate | 2001-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.